Latest News in the pharma Industry

Research & Development

FDA approves BMS's Opdivo for bladder cancer

FDA approves BMS's Opdivo for bladder cancer

5 Feb 2017

Opdivo has now been approved in six tumour types in just over 2 years.

Read more 
Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

Merck gets the thumbs up in Europe for Keytruda to treat patients with metastatic NSCLC

2 Feb 2017

First anti-PD-1 therapy approved in Europe for previously untreated patients with metastatic NSCLC.

Read more 
Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

Novartis' Votubia receives EU approval to treat refractory partial-onset seizures in patients with TSC

31 Jan 2017

Decision marks the third TSC-related indication for Votubia in the EU.

Read more 
FDA approves Allergan's sNDA for Avycaz to include new Phase III data in patients with cUTI

FDA approves Allergan's sNDA for Avycaz to include new Phase III data in patients with cUTI

30 Jan 2017

New clinical data for Avycaz demonstrates efficacy in cUTI patients including those with infections due to resistant Gram-negative pathogens.

Read more 
First adalimumab biosimilar candidate recommended for EMA approval

First adalimumab biosimilar candidate recommended for EMA approval

29 Jan 2017

Amgen receives positive CHMP opinion for biosimilar adalimumab.

Read more 
J&J to acquire Acelion for $30 B with spin-out of new R&D company

J&J to acquire Acelion for $30 B with spin-out of new R&D company

29 Jan 2017

Actelion R&D unit to spin out into standalone company based and listed in Switzerland.

Read more 
X4 Pharma initiates clinical study of X4P-001 in combination with Opdivo

X4 Pharma initiates clinical study of X4P-001 in combination with Opdivo

28 Jan 2017

Combination studied as treatment for patients with advanced clear cell renal cell carcinoma.

Read more 
Non-opiate painkiller, AnestaGel, found superior in preclinical tests

Non-opiate painkiller, AnestaGel, found superior in preclinical tests

26 Jan 2017

AnestaGel uses a novel approach to delivering sustained-released analgesics into the target tissue via the Matrix, which is a tunable, biocompatible, and pH neutral platform.

Read more 
Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum

Axim Biotech enters IBS clinical trial for CanChew CBD chewing gum

26 Jan 2017

Clinical trial is the first of its kind to treat IBS symptoms by cannabinoid-containing chewing gum.

Read more 
Clinerion introduces new services for market access

Clinerion introduces new services for market access

25 Jan 2017

Disease prevalence can be monitored with a precision never before possible.

Read more 
Zymeworks opens state-of-the-art lab facility

Zymeworks opens state-of-the-art lab facility

25 Jan 2017

Provides the company with increased control over discovery research, antibody generation, medicinal chemistry and bioconjugation for generating antibody drug conjugates.

Read more 
FDA approves IND for Vectura's VR647

FDA approves IND for Vectura's VR647

24 Jan 2017

VR647 is a drug/device combination, using the AKITA JET smart nebuliser, for the delivery of nebulised budesonide.

Read more